Dr. Gian Trepp, founder of GBT Pharma has been appointed by Creso Pharma as Commercial Advisor.
Having held worldwide executive leadership positions in General Management and Marketing for global pharmaceutical companies in Switzerland and the US, Gian brings over 18 years of strategic and operational leadership in the pharmaceutical field to the role.
Creso Pharma is working to develop and produce safe, cannabis- and hemp- derived therapeutic products and treatments for humans and pets. The nutraceutical and medical cannabis company, offers a range of products designed to create better overall health in humans and pets.
Speaking of his appointment, Gian said: “Cannabidiol (CBD) has shown therapeutic value for various diseases and conditions not least in the treatment of anxiety and stress.
“The new Cannaqix range from Creso pharma is a full plant hemp-based nutraceutical with an innovative delivery and dosage system and is totally unique in the sector. I am looking forward to working closely with Creso Pharma to bring this ground-breaking product to market in the coming months.”